⌘K

Login Start Free

Home/Filings/4/0001209191-22-027930

4//SEC Filing

Gandhi Leena 4

Accession 0001209191-22-027930

CIK 0001538210other

View on SEC.gov Company Profile

Filed

May 8, 8:00 PM ET

Accepted

May 9, 6:35 PM ET

Size

5.1 KB

Accession

0001209191-22-027930

Insider Transaction Report

Form 4

Period: 2022-05-05

NexImmune, Inc.NEXI

Director

Transactions

Award
Stock Option (Right to Buy)
2022-05-05+80,947→ 80,947 total
Exercise: $3.07Exp: 2032-05-04→ Common (80,947 underlying)

Footnotes (1)

[F1]This option shall vest in 36 equal monthly installments over the following three-year period.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NexImmune, Inc.

CIK 0001538210

Entity typeother

Related Parties

1

filerCIK 0001927002

Filing Metadata

Form type: 4
Filed: May 8, 8:00 PM ET
Accepted: May 9, 6:35 PM ET
Size: 5.1 KB

View on SEC.gov